Substance / Medication

Fomepizole

Overview

Active Ingredient
fomepizole
RxNorm CUI
15226

Indications

DOSAGE AND ADMINISTRATION see Fomepizole is indicated as an antidote for ethylene glycol (such as antifreeze) or methanol poisoning, or for use in suspected ethylene glycol or methanol ingestion, either alone or in combination with hemodialysis ().

Labeler: Zydus Pharmaceuticals USA Inc.Updated: 2025-11-20T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

Fomepizole should not be administered to patients with a documented serious hypersensitivity reaction to fomepizole or other pyrazoles.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

2 trials linked to this intervention

2
Total Trials
1
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Extracorporeal Membrane Oxygenation in Intoxication and Overdoses: A Systematic Review.
Maier Sven, Rösner Lisa, Saemann Lars et al. · Thorac Cardiovasc Surg · 2024
PMID: 36940708Meta-Analysis
Gastrointestinal decontamination using oil-based solutions in patients with acute aluminum phosphide poisoning: a systematic review and meta-analysis.
Hafez Amal S A F, Elgazzar Fatma M, Sobh Zahraa K et al. · Crit Rev Toxicol · 2024
PMID: 38656260Meta-Analysis
Chlorfenapyr poisoning: a systematic review.
Comstock Grant Thomas, Nguyen HoanVu, Bronstein Alvin et al. · Clin Toxicol (Phila) · 2024
PMID: 38984827Meta-Analysis
Pediatric poisoning deaths in Saudi Arabia: A systematic review.
Almutairi Saad A, Alsaleem Jassim Hijji, Alrashed Mahdi A et al. · Leg Med (Tokyo) · 2023
PMID: 36395600Meta-Analysis
Extracorporeal treatment for ethylene glycol poisoning: systematic review and recommendations from the EXTRIP workgroup.
Ghannoum Marc, Gosselin Sophie, Hoffman Robert S et al. · Crit Care · 2023
PMID: 36765419Meta-AnalysisFull text (PMC)
Fomepizole as an antidote for ethylene glycol poisoning.
Battistella Marisa · Ann Pharmacother · 2002
PMID: 12022913Meta-Analysis
Butanediol Conversion to Gamma-Hydroxybutyrate Markedly Reduced by the Alcohol Dehydrogenase Blocker Fomepizole.
Liakoni Evangelia, Gugelmann Hallam, Dempsey Delia A et al. · Clin Pharmacol Ther · 2019
PMID: 30450642RCTFull text (PMC)
Analysis of Fomepizole Elimination in Methanol- and Ethylene Glycol-Poisoned Patients.
McMartin Kenneth, Brent Jeffrey · J Med Toxicol · 2022
PMID: 34697779TrialFull text (PMC)
Fomepizole for the treatment of methanol poisoning.
Brent J, McMartin K, Phillips S et al. · N Engl J Med · 2001
PMID: 11172179Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Fomepizole (substance)
SNOMED CT
386970006
UMLS CUI
C0048504
RxNorm CUI
15226
Labeler
Zydus Pharmaceuticals USA Inc.

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
2
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.